Topics

Articles

Trade association is now big companies with big R&D spending

Takes reins with prior experience at both FDA and HHS

Latest QuintilesIMS report sees 5.8% growth in 2016; more emphasis on ‘net-price’ spending

EMD Serono Specialty Digest finds they struggle over 'ensuring clinically appropriate use'

Acquisition of PharmaMetrics adds payer analytics to Integrichain’s channel, pharmacy intelligence

‘Why fund your competitors?’ asks the company, in a pitch to independents served by the Big 3 wholesalers

$6.1-billion acquisition of Medtronic assets for patient care consumables

Reimbursement is just one of the issues facing biosimilar commercialization in the US

GPhA rebrands and aligns more closely with biosimilars